Buy Sun Pharmaceutical Industries, target price Rs 1225: ICICI Direct

ICICI Direct has buy call on Sun Pharmaceutical Industries with a target price of Rs 1225. The current market price of Sun Pharmaceutical Industries is Rs 1041.65.

Sun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 249542.83 Crore) operating in Pharmaceuticals sector.

Sun Pharmaceutical Industries key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.


Financials
For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 11037.50 Crore, up 2.54 % from last quarter Total Income of Rs 10763.90 Crore and up 12.07 % from last year same quarter Total Income of Rs 9848.82 Crore. Company has reported net profit after tax of Rs 2260.17 Crore in latest quarter.

The company’s top management includes Mr.Israel Makov, Mr.Dilip S Shanghvi, Mr.Sailesh T Desai, Mr.Kalyanasundaram Subramanian, Mr.Sudhir V Valia, Dr.Pawan Goenka, Mr.Rama Bijapurkar, Mr.Gautam Doshi. Company has S R B C & Co. LLP as its auditors. As on 31-12-2022, the company has a total of 240 Crore shares outstanding.

Investment Rationale
Higher contribution from specialty and strong domestic franchise is likely to change the product mix towards more remunerative businesses by FY23.